91 related articles for article (PubMed ID: 20303977)
1. The effects of phosphomimetic lid mutation on the thermostability of the N-terminal domain of MDM2.
Worrall EG; Worrall L; Blackburn E; Walkinshaw M; Hupp TR
J Mol Biol; 2010 May; 398(3):414-28. PubMed ID: 20303977
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the E3 ubiquitin ligase activity of MDM2 by an N-terminal pseudo-substrate motif.
Worrall EG; Wawrzynow B; Worrall L; Walkinshaw M; Ball KL; Hupp TR
J Chem Biol; 2009 Aug; 2(3):113-29. PubMed ID: 19568783
[TBL] [Abstract][Full Text] [Related]
3. Phosphomimetic mutation of the N-terminal lid of MDM2 enhances the polyubiquitination of p53 through stimulation of E2-ubiquitin thioester hydrolysis.
Fraser JA; Worrall EG; Lin Y; Landre V; Pettersson S; Blackburn E; Walkinshaw M; Muller P; Vojtesek B; Ball K; Hupp TR
J Mol Biol; 2015 Apr; 427(8):1728-47. PubMed ID: 25543083
[TBL] [Abstract][Full Text] [Related]
4. Identification of a second Nutlin-3 responsive interaction site in the N-terminal domain of MDM2 using hydrogen/deuterium exchange mass spectrometry.
Hernychova L; Man P; Verma C; Nicholson J; Sharma CA; Ruckova E; Teo JY; Ball K; Vojtesek B; Hupp TR
Proteomics; 2013 Aug; 13(16):2512-25. PubMed ID: 23776060
[TBL] [Abstract][Full Text] [Related]
5. Role of Mdm2 acid domain interactions in recognition and ubiquitination of the transcription factor IRF-2.
Pettersson S; Kelleher M; Pion E; Wallace M; Ball KL
Biochem J; 2009 Mar; 418(3):575-85. PubMed ID: 19032150
[TBL] [Abstract][Full Text] [Related]
6. Chemical states of the N-terminal "lid" of MDM2 regulate p53 binding: simulations reveal complexities of modulation.
Dastidar SG; Raghunathan D; Nicholson J; Hupp TR; Lane DP; Verma CS
Cell Cycle; 2011 Jan; 10(1):82-9. PubMed ID: 21191186
[TBL] [Abstract][Full Text] [Related]
7. A second p53 binding site in the central domain of Mdm2 is essential for p53 ubiquitination.
Ma J; Martin JD; Zhang H; Auger KR; Ho TF; Kirkpatrick RB; Grooms MH; Johanson KO; Tummino PJ; Copeland RA; Lai Z
Biochemistry; 2006 Aug; 45(30):9238-45. PubMed ID: 16866370
[TBL] [Abstract][Full Text] [Related]
8. Dual-site regulation of MDM2 E3-ubiquitin ligase activity.
Wallace M; Worrall E; Pettersson S; Hupp TR; Ball KL
Mol Cell; 2006 Jul; 23(2):251-63. PubMed ID: 16857591
[TBL] [Abstract][Full Text] [Related]
9. MDM2 protein-mediated ubiquitination of numb protein: identification of a second physiological substrate of MDM2 that employs a dual-site docking mechanism.
Sczaniecka M; Gladstone K; Pettersson S; McLaren L; Huart AS; Wallace M
J Biol Chem; 2012 Apr; 287(17):14052-68. PubMed ID: 22337874
[TBL] [Abstract][Full Text] [Related]
10. Simulating molecular mechanisms of the MDM2-mediated regulatory interactions: a conformational selection model of the MDM2 lid dynamics.
Verkhivker GM
PLoS One; 2012; 7(7):e40897. PubMed ID: 22815859
[TBL] [Abstract][Full Text] [Related]
11. Interrogation of MDM2 phosphorylation in p53 activation using native chemical ligation: the functional role of Ser17 phosphorylation in MDM2 reexamined.
Zhan C; Varney K; Yuan W; Zhao L; Lu W
J Am Chem Soc; 2012 Apr; 134(15):6855-64. PubMed ID: 22444248
[TBL] [Abstract][Full Text] [Related]
12. Impact of Ser17 Phosphorylation on the Conformational Dynamics of the Oncoprotein MDM2.
Bueren-Calabuig JA; Michel J
Biochemistry; 2016 May; 55(17):2500-9. PubMed ID: 27050388
[TBL] [Abstract][Full Text] [Related]
13. Quantitative lid dynamics of MDM2 reveals differential ligand binding modes of the p53-binding cleft.
Showalter SA; Bruschweiler-Li L; Johnson E; Zhang F; Brüschweiler R
J Am Chem Soc; 2008 May; 130(20):6472-8. PubMed ID: 18435534
[TBL] [Abstract][Full Text] [Related]
14. The conformationally flexible S9-S10 linker region in the core domain of p53 contains a novel MDM2 binding site whose mutation increases ubiquitination of p53 in vivo.
Shimizu H; Burch LR; Smith AJ; Dornan D; Wallace M; Ball KL; Hupp TR
J Biol Chem; 2002 Aug; 277(32):28446-58. PubMed ID: 11925449
[TBL] [Abstract][Full Text] [Related]
15. Destabilizing missense mutations in the tumour suppressor protein p53 enhance its ubiquitination in vitro and in vivo.
Shimizu H; Saliba D; Wallace M; Finlan L; Langridge-Smith PR; Hupp TR
Biochem J; 2006 Jul; 397(2):355-67. PubMed ID: 16579792
[TBL] [Abstract][Full Text] [Related]
16. A novel p53 phosphorylation site within the MDM2 ubiquitination signal: II. a model in which phosphorylation at SER269 induces a mutant conformation to p53.
Fraser JA; Madhumalar A; Blackburn E; Bramham J; Walkinshaw MD; Verma C; Hupp TR
J Biol Chem; 2010 Nov; 285(48):37773-86. PubMed ID: 20847049
[TBL] [Abstract][Full Text] [Related]
17. Solution structure of the Hdm2 C2H2C4 RING, a domain critical for ubiquitination of p53.
Kostic M; Matt T; Martinez-Yamout MA; Dyson HJ; Wright PE
J Mol Biol; 2006 Oct; 363(2):433-50. PubMed ID: 16965791
[TBL] [Abstract][Full Text] [Related]
18. C-terminal region of USP7/HAUSP is critical for deubiquitination activity and contains a second mdm2/p53 binding site.
Ma J; Martin JD; Xue Y; Lor LA; Kennedy-Wilson KM; Sinnamon RH; Ho TF; Zhang G; Schwartz B; Tummino PJ; Lai Z
Arch Biochem Biophys; 2010 Nov; 503(2):207-12. PubMed ID: 20816748
[TBL] [Abstract][Full Text] [Related]
19. Functional Interrogation of the N-Terminal Lid of MDMX in p53 Binding via Native Chemical Ligation.
Chen X; Lu W
Chem Pharm Bull (Tokyo); 2016; 64(7):1004-8. PubMed ID: 27373663
[TBL] [Abstract][Full Text] [Related]
20. Kinetic and thermodynamic effects of phosphorylation on p53 binding to MDM2.
Yadahalli S; Neira JL; Johnson CM; Tan YS; Rowling PJE; Chattopadhyay A; Verma CS; Itzhaki LS
Sci Rep; 2019 Jan; 9(1):693. PubMed ID: 30679555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
